Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$13.58 USD
-0.09 (-0.62%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $13.66 +0.09 (0.63%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.58 USD
-0.09 (-0.62%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $13.66 +0.09 (0.63%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Zacks News
Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of -2.94% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Sabra (SBRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Alexander's (ALX) Lags Q4 FFO Estimates
by Zacks Equity Research
Alexander's (ALX) delivered FFO and revenue surprises of -16.13% and 13.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KBWY
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Lamar Advertising (LAMR) Beats Q3 FFO Estimates
by Zacks Equity Research
Lamar (LAMR) delivered FFO and revenue surprises of 6.81% and 0.16%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KBWY
Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sabra Healthcare (SBRA) Q2 FFO Meet Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 0% and 1.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CubeSmart (CUBE) Q2 FFO and Revenues Lag Estimates
by Zacks Equity Research
CubeSmart (CUBE) delivered FFO and revenue surprises of -1.49% and 0.62%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Summit Hotel Properties (INN) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
Summit Hotel Properties (INN) delivered FFO and revenue surprises of 28.57% and 1.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sabra Healthcare (SBRA) Matches Q1 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Welltower (WELL) Q1 FFO and Revenues Beat Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 3.66% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Stag Industrial (STAG) Meets Q1 FFO Estimates
by Zacks Equity Research
Stag (STAG) delivered FFO and revenue surprises of 0% and 1.96%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Sabra Healthcare REIT (SBRA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Sabra Healthcare REIT (SBRA) stock based on the movements in the options market lately.
Implied Volatility Surging for Sabra Health Care (SBRA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Sabra Health Care (SBRA) stock based on the movements in the options market lately.
Sabra Healthcare (SBRA) Beats Q4 FFO and Revenue Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 2.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Q3 FFO and Revenues Miss Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of -5.26% and 10.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Americold Realty Trust Inc. (COLD) Surpasses Q3 FFO Estimates
by Zacks Equity Research
Americold Realty Trust Inc. (COLD) delivered FFO and revenue surprises of 16% and 0.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Park Hotels & Resorts (PK) Q3 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Park Hotels & Resorts (PK) delivered FFO and revenue surprises of 5% and 1.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Industrial Logistics Properties Trust (ILPT) Lags Q3 FFO and Revenue Estimates
by Zacks Equity Research
Industrial Logistics Properties Trust (ILPT) delivered FFO and revenue surprises of -30.30% and 1.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra (SBRA) Stock Jumps 5.5%: Will It Continue to Soar?
by Zacks Equity Research
Sabra (SBRA) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might help the stock continue moving higher in the near term.
Sabra Healthcare (SBRA) Surpasses Q2 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 5.41% and 2.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?